AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion
The deal is AbbVie's latest attempt to expand its drug pipeline as its top-selling treatments, such as Humira, face generic competition.
Source link
The deal is AbbVie's latest attempt to expand its drug pipeline as its top-selling treatments, such as Humira, face generic competition.
Source link
/cloudfront-us-east-2.images.arcpublishing.com/reuters/QACFPFQNABPN5NA6GCH7LZCEHM.jpg "COVID cases break records in Europe, prompting booster shot rethink")
